Compound Profile: Eli
Eli 20 mg Pharmaceutical is a tadalafil citrate compound supplied for in-vitro laboratory research purposes. Tadalafil citrate belongs to the phosphodiesterase type 5 (PDE5) inhibitor class, characterised by its selective inhibition of cyclic guanosine monophosphate-specific phosphodiesterase type 5. This pharmaceutical-grade research material enables investigators to examine the biochemical properties and cellular mechanisms of PDE5 inhibition in controlled laboratory environments. Researchers at Stroid UK Shop source this compound for studying vasodilation pathways and nitric oxide signalling cascades.
Laboratory Applications
Research scientists investigate tadalafil citrate for its selective enzyme inhibition properties in cellular models. The compound demonstrates potent inhibitory activity against PDE5 enzymes whilst maintaining selectivity over other phosphodiesterase subtypes. Laboratory studies examine its effects on cyclic nucleotide metabolism and smooth muscle cell function in tissue culture systems. Investigators utilise this material to study endothelial function, vascular biology, and cellular signalling pathways related to nitric oxide synthesis. Comparative studies often evaluate tadalafil alongside other compounds from our erection drugs research collection, SARMs portfolio, and peptides range for comprehensive research protocols.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Tadalafil Citrate |
| Concentration | 20 mg per tablet |
| Form | Pharmaceutical tablet |
| Molecular Formula | C₂₂H₁₉N₃O₄ |
| Molecular Weight | 389.40 g/mol |
| CAS Number | 171596-29-5 |
| Storage Requirements | Room temperature, dry environment |
| Stability | 36 months when stored properly |
Research Compliance
Eli 20 mg Pharmaceutical is supplied exclusively for in-vitro laboratory research applications. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Investigators must ensure compliance with institutional review board guidelines and applicable laboratory safety protocols when handling this research material. All studies should be conducted in appropriate laboratory facilities with qualified personnel and proper documentation procedures.
